相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nonalcoholic Fatty Liver Disease 2020: The State of the Disease
Thomas G. Cotter et al.
GASTROENTEROLOGY (2020)
An AMPK-caspase-6 axis controls liver damage in nonalcoholic steatohepatitis
Peng Zhao et al.
SCIENCE (2020)
Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation
Jamie Bates et al.
JOURNAL OF HEPATOLOGY (2020)
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam et al.
JOURNAL OF HEPATOLOGY (2020)
From overnutrition to liver injury: AMP-activated protein kinase in nonalcoholic fatty liver diseases
Peng Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Activation of Adenosine Monophosphate-Activated Protein Kinase Reduces the Onset of Diet-Induced Hepatocellular Carcinoma in Mice
Dieter Schmoll et al.
HEPATOLOGY COMMUNICATIONS (2020)
AMP-activated protein kinase: the current landscape for drug development
Gregory R. Steinberg et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Konstantin Kazankov et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Genetic Liver-Specific AMPK Activation Protects against Diet-Induced Obesity and NAFLD
Daniel Garcia et al.
CELL REPORTS (2019)
The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity
Mikhail A. Van Herck et al.
FRONTIERS IN IMMUNOLOGY (2019)
Targeting Myeloid-Derived Cells: New Frontiers in the Treatment of Non-alcoholic and Alcoholic Liver Disease
Luisa Vonghia et al.
FRONTIERS IN IMMUNOLOGY (2019)
Triggering and resolution of inflammation in NASH
Susanne Schuster et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis
Kirstine S. Tolbol et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
AMPK Re-Activation Suppresses Hepatic Steatosis but its Downregulation Does Not Promote Fatty Liver Development
Nadia Boudaba et al.
EBIOMEDICINE (2018)
Activation of Liver AMPK with PF-06409577 Corrects NAFLD and Lowers Cholesterol in Rodent and Primate Preclinical Models
Ryan M. Esquejo et al.
EBIOMEDICINE (2018)
AMPK activation by A-769662 and 991 does not affect catecholamine-induced lipolysis in human adipocytes
Franziska Kopietz et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2018)
Conformational heterogeneity of the allosteric drug and metabolite (ADaM) site in AMP-activated protein kinase (AMPK)
Xin Gu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Pathogenesis of Nonalcoholic Steatohepatitis and Hormone-Based Therapeutic Approaches
Kook Hwan Kim et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Liver Fat Accumulation as a Barometer of Insulin Responsiveness Again Points to Adipose Tissue as the Culprit
Fernando Bril et al.
HEPATOLOGY (2017)
Activation of AMP-activated protein kinase rapidly suppresses multiple pro-inflammatory pathways in adipocytes including IL-1 receptor-associated kinase-4 phosphorylation
Sarah J. Mancini et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2017)
Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy
Robert W. Myers et al.
SCIENCE (2017)
AMPK: a novel target for treating hepatic fibrosis
Zhenxing Liang et al.
ONCOTARGET (2017)
Liver-Specific Activation of AMPK Prevents Steatosis on a High-Fructose Diet
Angela Woods et al.
CELL REPORTS (2017)
Non-alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes
Kenneth Cusi et al.
DIABETES OBESITY & METABOLISM (2017)
Activation of Skeletal Muscle AMPK Promotes Glucose Disposal and Glucose Lowering in Non-human Primates and Mice
Emily C. Cokorinos et al.
CELL METABOLISM (2017)
Treatment of nonalcoholic fatty liver disease: role of AMPK
Brennan K. Smith et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
AMPK Phosphorylates Desnutrin/ATGL and Hormone-Sensitive Lipase To Regulate Lipolysis and Fatty Acid Oxidation within Adipose Tissue
Sun-Joong Kim et al.
MOLECULAR AND CELLULAR BIOLOGY (2016)
Obese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsy
Maria Nicoline Baandrup Kristiansen et al.
WORLD JOURNAL OF HEPATOLOGY (2016)
Adenosine 5′-Monophosphate-Activated Protein Kinase Regulates IL-10-Mediated Anti-Inflammatory Signaling Pathways in Macrophages
Yanfang Peipei Zhu et al.
JOURNAL OF IMMUNOLOGY (2015)
Small Molecule Drug A-769662 and AMP Synergistically Activate Naive AMPK Independent of Upstream Kinase Signaling
John W. Scott et al.
CHEMISTRY & BIOLOGY (2014)
Increased De Novo Lipogenesis Is a Distinct Characteristic of Individuals With Nonalcoholic Fatty Liver Disease
Jennifer E. Lambert et al.
GASTROENTEROLOGY (2014)
Dendritic cells limit fibroinflammatory injury in nonalcoholic steatohepatitis in mice
Justin R. Henning et al.
HEPATOLOGY (2013)
AMPK, insulin resistance, and the metabolic syndrome
Neil B. Ruderman et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin
Morgan D. Fullerton et al.
NATURE MEDICINE (2013)
Structural basis of AMPK regulation by small molecule activators
Bing Xiao et al.
NATURE COMMUNICATIONS (2013)
Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications
Kenneth Cusi
GASTROENTEROLOGY (2012)
Insulin sensitive and resistant obesity in humans: AMPK activity, oxidative stress, and depot-specific changes in gene expression in adipose tissue
X. Julia Xu et al.
JOURNAL OF LIPID RESEARCH (2012)
Decreased AMP-activated protein kinase activity is associated with increased inflammation in visceral adipose tissue and with whole-body insulin resistance in morbidly obese humans
Marie-Soleil Gauthier et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Hematopoietic AMPK β1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity
Sandra Galic et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
NF-κB in the liver-linking injury, fibrosis and hepatocellular carcinoma
Tom Luedde et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
A Potent and Selective AMPK Activator That Inhibits de Novo Lipogenesis
Jorge E. Gomez-Galeno et al.
ACS MEDICINAL CHEMISTRY LETTERS (2010)
High molecular weight adiponectin inhibits proliferation of hepatic stellate cells via activation of adenosine monophosphate-activated protein kinase
Masayuki Adachi et al.
HEPATOLOGY (2008)
Adenosine 5′-Monophosphate-Activated Protein Kinase Promotes Macrophage Polarization to an Anti-Inflammatory Functional Phenotype
Duygu Sag et al.
JOURNAL OF IMMUNOLOGY (2008)
Defining the mechanism of activation of AMP-activated protein kinase by the small molecule A-769662, a member of the thienopyridone family
Matthew J. Sanders et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade
Matthew J. Sanders et al.
BIOCHEMICAL JOURNAL (2007)
Tumor necrosis factor α-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling
Gregory R. Steinberg et al.
CELL METABOLISM (2006)
Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome
Barbara Cool et al.
CELL METABOLISM (2006)
分享论文
